Ifm Investors Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History

Ifm Investors Pty LTD

  • $10.3 Billion
  • Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifm Investors Pty LTD holds 23,285 shares of REGN stock, worth $16.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
23,285
Previous 23,258 0.12%
Holding current value
$16.8 Million
Previous $24.4 Million 0.14%
% of portfolio
0.24%
Previous 0.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$1024.09 - $1201.76 $27,650 - $32,447
27 Added 0.12%
23,285 $24.5 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $609,408 - $739,121
690 Added 3.06%
23,258 $24.4 Million
Q1 2024

Apr 22, 2024
SELL
$902.69 - $993.35 $120,960 - $133,108
-134 Reduced 0.59%
22,568 $21.7 Million
Q4 2023

Jan 12, 2024
SELL
$775.18 - $881.7 $44,960 - $51,138
-58 Reduced 0.25%
22,702 $19.9 Million
Q3 2023

Oct 26, 2023
BUY
$692.45 - $844.37 $1.29 Million - $1.57 Million
1,859 Added 8.89%
22,760 $18.7 Million
Q2 2023

Jul 27, 2023
BUY
$700.03 - $830.35 $731,531 - $867,715
1,045 Added 5.26%
20,901 $15 Million
Q1 2023

May 11, 2023
BUY
$680.49 - $826.97 $317,108 - $385,368
466 Added 2.4%
19,856 $16.3 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $353,650 - $383,961
501 Added 2.65%
19,390 $14 Million
Q3 2022

Oct 12, 2022
BUY
$573.97 - $724.32 $215,812 - $272,344
376 Added 2.03%
18,889 $13 Million
Q2 2022

Jul 15, 2022
BUY
$548.35 - $738.84 $605,378 - $815,679
1,104 Added 6.34%
18,513 $10.9 Million
Q1 2022

Apr 13, 2022
BUY
$595.12 - $698.43 $2.18 Million - $2.56 Million
3,659 Added 26.61%
17,409 $12.2 Million
Q4 2021

Jan 18, 2022
SELL
$543.48 - $670.97 $35,869 - $44,284
-66 Reduced 0.48%
13,750 $8.68 Million
Q3 2021

Oct 13, 2021
SELL
$574.03 - $680.96 $20,091 - $23,833
-35 Reduced 0.25%
13,816 $8.36 Million
Q2 2021

Jul 16, 2021
BUY
$472.8 - $558.54 $1.09 Million - $1.29 Million
2,308 Added 19.99%
13,851 $7.74 Million
Q1 2021

May 05, 2021
BUY
$446.73 - $548.2 $680,369 - $834,908
1,523 Added 15.2%
11,543 $5.46 Million
Q4 2020

Jan 13, 2021
BUY
$478.3 - $607.98 $831,763 - $1.06 Million
1,739 Added 21.0%
10,020 $4.84 Million
Q3 2020

Oct 16, 2020
BUY
$544.75 - $658.21 $616,657 - $745,093
1,132 Added 15.83%
8,281 $4.64 Million
Q2 2020

Jul 13, 2020
SELL
$493.32 - $643.92 $545,611 - $712,175
-1,106 Reduced 13.4%
7,149 $4.46 Million
Q1 2020

Apr 09, 2020
BUY
$336.18 - $494.43 $83,708 - $123,113
249 Added 3.11%
8,255 $3.91 Million
Q4 2019

Jan 13, 2020
SELL
$274.13 - $376.51 $94,026 - $129,142
-343 Reduced 4.11%
8,006 $3.01 Million
Q3 2019

Nov 01, 2019
BUY
$273.46 - $318.39 $660,405 - $768,911
2,415 Added 40.7%
8,349 $2.32 Million
Q2 2019

Jul 16, 2019
BUY
$299.6 - $414.82 $176,164 - $243,914
588 Added 11.0%
5,934 $1.86 Million
Q1 2019

Apr 18, 2019
BUY
$372.08 - $439.57 $284,641 - $336,271
765 Added 16.7%
5,346 $2.2 Million
Q4 2018

Jan 23, 2019
BUY
$335.82 - $403.04 $143,059 - $171,695
426 Added 10.25%
4,581 $1.71 Million
Q3 2018

Oct 22, 2018
BUY
$351.14 - $408.51 $206,470 - $240,203
588 Added 16.48%
4,155 $1.68 Million
Q2 2018

Jul 09, 2018
BUY
$284.6 - $344.99 $317,329 - $384,663
1,115 Added 45.47%
3,567 $1.23 Million
Q1 2018

May 11, 2018
BUY
$315.82 - $393.78 $82,744 - $103,170
262 Added 11.96%
2,452 $844,000
Q3 2017

Nov 16, 2017
BUY
$431.38 - $504.0 $19,412 - $22,680
45 Added 2.1%
2,190 $979,000
Q2 2017

Nov 21, 2017
BUY
N/A
2,145 New
2,145 $1.05 Million
Q2 2017

Aug 10, 2017
SELL
N/A
-1,628 Closed
0 $0
Q1 2017

Nov 21, 2017
BUY
N/A
1,628
1,628 $631,000

Others Institutions Holding REGN

# of Institutions
1,488
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email